Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exubera availability trial in poorly controlled type 2 diabetes
2004-001258-94Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2004
- Countries
- 1
01
Overview
Phase 3, open-label trial of Technosphere insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Pfizer. Primary endpoints: Change in HbA1c at 26 weeks and HbA1c difference from baseline to week 52. Started Oct 2004; status: completed.
02
Drugs
Technosphere insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-001258-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001258-94.